Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction
J. P. Depta, P. A. Lenzini, D. E. Lanfear, T. Y. Wang, J. A. Spertus, R. G. Bach, S. Cresci
Dive into the research topics of 'Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction'. Together they form a unique fingerprint.